WELCOME TO AhR PHARMACEUTICALS!

The AhR Pharmaceuticals, Inc. is a pharmaceutical research and development company, a type C Wisconsin corporation based in Madison, Wisconsin, USA. The company is devoted to the development of a newly discovered natural hormone or endogenous ligand or physiological ligand named ITE, 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester, for a receptor called aryl hydrocarbon (Ah) receptor (AhR) into an efficacious and sustainable but low side-effect therapeutic agent in combating cancer, obesity, and disorders related to imbalanced actions of the immune system.
 
To review the scientific foundation of the corporation, please click Sci. Foundation.
 
To review a novel concept in cancer therapy, which will be high in efficacy (with a high possibility of cancer eradication) and sustainability but low in side effect, please click Cancer Therapy.
 
To read about what we have been doing and what we have achieved so far in our product development program, please visit our Product Development page.
 
We would like to hear from you. Please click Contact Us for your comments, questions, and suggestions.